Paper19008445
Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity.
Hildner K and 12 others. Science, 2008. Cited by 1,775 papers, by iCite.
Cite this record
ConductScience Library. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Papers, record 19008445. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19008445
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Basic-Leucine Zipper Transcription Factors | Major topic |
| CD8 Antigens | Major topic |
| Cross-Priming | Major topic |
| Cytotoxicity, Immunologic | Major topic |
| Dendritic Cells | Major topic |
| Repressor Proteins | Major topic |
| T-Lymphocytes, Cytotoxic | Major topic |
| Adoptive Transfer | |
| Animals | |
| Antibodies, Viral | |
| CD4-Positive T-Lymphocytes | |
| Female | |
| Fibrosarcoma | |
| Lymphocyte Activation | |
| Male | |
| Mice | |
| Mice, Inbred C57BL | |
| Spleen | |
| West Nile Fever | |
| West Nile virus |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Howard Hughes Medical Institute | United States | PubMed |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT03792724 | Phase I-II Study of Intratumoral Urelumab Combined With Nivolumab in Patients With Solid Tumors | Background | ClinicalTrials.gov | |
| NCT04789252 | Heterogeneity of Dendritic Cells in Colon and Non-small Cell Lung Cancer | Background | ClinicalTrials.gov |
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10878360 | Repression of IL-2 promoter activity by the novel basic leucine zipper p21SNFT protein. | J Immunol | 2000 | https://conductscience.org/library/papers/10878360 | PubMed |
| 2 | 9553774 | Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. | Immunol Cell Biol | 1998 | https://conductscience.org/library/papers/9553774 | PubMed |
| 3 | 18268517 | The cell biology of cross-presentation and the role of dendritic cell subsets. | Immunol Cell Biol | 2008 | https://conductscience.org/library/papers/18268517 | PubMed |
| 4 | 11120766 | CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. | J Exp Med | 2000 | https://conductscience.org/library/papers/11120766 | PubMed |
| 5 | 17878350 | Skin-derived dendritic cells can mediate deletional tolerance of class I-restricted self-reactive T cells. | J Immunol | 2007 | https://conductscience.org/library/papers/17878350 | PubMed |
| 6 | 1083422 | Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. | J Exp Med | 1976 | https://conductscience.org/library/papers/1083422 | PubMed |
| 7 | 16045728 | Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells. | Clin Exp Immunol | 2005 | https://conductscience.org/library/papers/16045728 | PubMed |
| 8 | 11564769 | Redundancy of direct priming and cross-priming in tumor-specific CD8+ T cell responses. | J Immunol | 2001 | https://conductscience.org/library/papers/11564769 | PubMed |
| 9 | 12551996 | B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. | J Virol | 2003 | https://conductscience.org/library/papers/12551996 | PubMed |
| 10 | 7513904 | Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. | Science | 1994 | https://conductscience.org/library/papers/7513904 | PubMed |
| 11 | 15163797 | Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15163797 | PubMed |
| 12 | 12196292 | In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. | Immunity | 2002 | https://conductscience.org/library/papers/12196292 | PubMed |
| 13 | 15972648 | CD8alpha+ dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo. | J Immunol | 2005 | https://conductscience.org/library/papers/15972648 | PubMed |
| 14 | 17204652 | Differential antigen processing by dendritic cell subsets in vivo. | Science | 2007 | https://conductscience.org/library/papers/17204652 | PubMed |
| 15 | 12816982 | Relationships among murine CD11c(high) dendritic cell subsets as revealed by baseline gene expression patterns. | J Immunol | 2003 | https://conductscience.org/library/papers/12816982 | PubMed |
| 16 | 15951814 | A critical function for type I interferons in cancer immunoediting. | Nat Immunol | 2005 | https://conductscience.org/library/papers/15951814 | PubMed |
| 17 | 11323675 | IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. | Nature | 2001 | https://conductscience.org/library/papers/11323675 | PubMed |
| 18 | 18086865 | Identification of a novel population of Langerin+ dendritic cells. | J Exp Med | 2007 | https://conductscience.org/library/papers/18086865 | PubMed |
| 19 | 17035323 | CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system. | J Virol | 2006 | https://conductscience.org/library/papers/17035323 | PubMed |
| 20 | 16415871 | Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. | Nat Immunol | 2006 | https://conductscience.org/library/papers/16415871 | PubMed |
Cited by1,325
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,775 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42982509 | Harnessing inflammatory monocytes to overcome resistance to anti-PD-1 immunotherapy. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42982509 | PubMed |
| 42954729 | Irradiated dendritic cell subsets retain key immune capabilities and anti-tumor immunity is not strictly dependent on cDC1. | Oncoimmunology | 2026 | https://conductscience.org/library/papers/42954729 | PubMed |
| 42947546 | Generating and Expanding Conventional Type 1 Dendritic Cells. | Eur J Immunol | 2026 | https://conductscience.org/library/papers/42947546 | PubMed |
| 42909963 | Advancing osteosarcoma treatment: the impact of intratumoral metabolic reprogramming on immunotherapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42909963 | PubMed |
| 42899189 | Scalable generation of pure CD103+ cDC1 from iDC1 cultures. | Myeloid Cells | 2026 | https://conductscience.org/library/papers/42899189 | PubMed |
| 42899013 | Innate immune cells in tumor immunity: dual roles, mechanistic insights, and therapeutic opportunities. | Front Immunol | 2026 | https://conductscience.org/library/papers/42899013 | PubMed |
| 42897144 | Distinct migratory dendritic cell subsets cooperate to prime tissue-resident memory-like CD8⁺ T cells in mouse tumors. | Nat Commun | 2026 | https://conductscience.org/library/papers/42897144 | PubMed |
| 42885991 | Immune Landscape and Intercellular Crosstalk in the Cornea of an Autoimmune-Mediated Dry Eye Disease. | Invest Ophthalmol Vis Sci | 2026 | https://conductscience.org/library/papers/42885991 | PubMed |
| 42866402 | Myeloid control of dendritic cell priming after mechanical HIFU in colorectal cancer: implications for PD-1/PD-L1 blockade. | Front Immunol | 2026 | https://conductscience.org/library/papers/42866402 | PubMed |
| 42840974 | In situ vaccination for the treatment of localized cancer and the prevention of metastatic disease. | Front Immunol | 2026 | https://conductscience.org/library/papers/42840974 | PubMed |
| 42777708 | CD4 T cells convert transient responses to KRAS inhibition to durable remissions in pancreatic cancer. | Cell | 2026 | https://conductscience.org/library/papers/42777708 | PubMed |
| 42773266 | Metastasis enables immunogenicity through migrasome-mediated antigen release. | Nat Immunol | 2026 | https://conductscience.org/library/papers/42773266 | PubMed |
| 42769647 | Beyond the tumor microenvironment: a hierarchical immune-circuit model of immune checkpoint blockade resistance. | Front Oncol | 2026 | https://conductscience.org/library/papers/42769647 | PubMed |
| 42731874 | Epigenetic plus cytokine therapy induces stem-like CD8+ T-cell reservoirs and intratumoral immune niches to overcome anti-PD-1 resistance. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42731874 | PubMed |
| 42722716 | αTIGIT-guided IL-15 mimetics drive potent and safe antitumor immunity by restoring tumor-infiltrating T cells. | Cell Mol Immunol | 2026 | https://conductscience.org/library/papers/42722716 | PubMed |
| 42705236 | Dendritic cell centric nanoengineering couples antigen acquisition and STING activation for cancer immunotherapy. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42705236 | PubMed |
| 42704368 | TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment. | J Exp Med | 2026 | https://conductscience.org/library/papers/42704368 | PubMed |
| 42695424 | Dendritic cell‑based vaccines for colorectal cancer: Mechanisms, clinical progress and future directions (Review). | Int J Oncol | 2026 | https://conductscience.org/library/papers/42695424 | PubMed |
| 42693199 | Priming of CD8+ T cells by peripheral dendritic cells exacerbates tau-mediated neurodegeneration. | Nat Neurosci | 2026 | https://conductscience.org/library/papers/42693199 | PubMed |
| 42675490 | Resetting the immune setpoint of cold tumors through a ferroptosis-cGAS-STING amplification circuit. | J Transl Med | 2026 | https://conductscience.org/library/papers/42675490 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19008445
GET https://conductscience.org/api/papers/v1/19008445/references?page=2